India launches probe as Chinese company recalls BP drug
Valsartan is used to treat patients with high blood pressure in order to reduce complications such as heart attack and stroke. Both the importer and the manufacturer, Zhejiang Huahai Pharmaceuticals, will be issued notice soon. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2018 Category: Pharmaceuticals Source Type: news

E-commerce players brace for big battle over online pharma
Flipkart, Amazon, BigBasket and Swiggy are all in exploratory talks to acquire, partner or invest in online pharma players. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2018 Category: Pharmaceuticals Source Type: news

Sun Pharma gets USFDA nod for cancer treatment injection
The approval from the USFDA is for INFUGEM injection (gemcitabine in 0.9 per cent sodium chloride injection) 10 mg/mL, for intravenous use in a ready-to-administer bag, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 18, 2018 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod to market 4 generic products
Pharma firm Zydus Cadila today said it has received final approvals from the US health regulator to market four generic products in America. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 18, 2018 Category: Pharmaceuticals Source Type: news

Daiichi-Ranbaxy row: HC directs Singh brothers to disclose foreign bank accounts, assets
The court had directed the local commissioner to sell the entire lot of unencumbered shares of the respondents, other than Malvinder Singh in listed companies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 18, 2018 Category: Pharmaceuticals Source Type: news

US trade under a cloud, China opens to Indian pharma
Indian firms are looking to fill gaps in Chinese demand for generic drugs, software, sugar and some varieties of rice, trade officials in New Delhi said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 14, 2018 Category: Pharmaceuticals Source Type: news

Suresh Prabhu asks pharma companies to invest in R & D
Commerce and Industry Minister Suresh Prabhu today asked pharmaceutical companies to invest in R&D to bolster the growth of the sector. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 13, 2018 Category: Pharmaceuticals Source Type: news

CCI penalises Glenmark Pharma, other entities for unfair business practices
All the entities have been fined for violating competition norms with regard to mandating no-objection certificates (NOC) from the associations prior to appointing entities as stockists. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 13, 2018 Category: Pharmaceuticals Source Type: news

Cipla's subsidiary to buy South Africa's Mirren for 450 mn South African Rand
Cipla said the acquisition of Mirren, which specialises in over the counter (OTC) pharmaceutical products, will strengthen its market position and help it to accelerate growth within OTC space. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 12, 2018 Category: Pharmaceuticals Source Type: news

Glenmark launches Akynzeo in India under licensing pact with Helsinn
Glenmark Pharmaceuticals today launched Akynzeo, a drug used for prevention chemotherapy-induced nausea and vomiting, in India and Nepal. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 12, 2018 Category: Pharmaceuticals Source Type: news

Sun Pharma's subsidiary files patent infringement suit against German drug maker Biofrontera
DUSA has alleged that Biofrontera defendants misappropriated confidential and trade secret information from DUSA and improperly obtained confidential DUSA information from its former employees to sell and market their own products. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 11, 2018 Category: Pharmaceuticals Source Type: news

Biocon puts arthritis drug on backburner
Biocon and Mylan have been working for a decade on a biosimilar version of the drug, originally sold by Amgen under brand name Enbrel. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 11, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma gets USFDA nod for infection treatment drug
The approval has been granted in the strengths of 250 mg and 500 mg, and the product will be launched this month, Aurobindo Pharma said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 11, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo in last lap to buy Mallinckrodt ’s US generics business
Mallinckrodt has the world ’s most diverse line of bulk medicinal controlled substances including fentanyl, methadone, hydrocodone, hydromorphone, oxycodone, morphine and codeine-based drugs. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 10, 2018 Category: Pharmaceuticals Source Type: news

China agrees to cut tariffs on Indian cancer drugs: Foreign Ministry
India has been demanding opening of China's IT and pharmaceutical sectors as part of measures to reduce over USD 51 billion trade deficit in over USD 84 billion bilateral trade. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 9, 2018 Category: Pharmaceuticals Source Type: news

TPG to acquire 40% in Sai Life for Rs 900 crore
TPG will seal the deal through secondary share purchase from existing investor Tata Capital, followed by a primary infusion into the two-decade-old company. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 7, 2018 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA's tentative nod for Deferasirox tablets
The group now has 202 approvals and has so far filed over 330 abbreviated new drug applications (ANDAs) since the commencement of the filing process in 2003-04. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 7, 2018 Category: Pharmaceuticals Source Type: news

Dr.Reddys bullish about better sales in Europe in FY19
Dr Reddys registered eight per cent growth in revenues form Europe to Rs 822 crore during last year, the Q4 of the Fy 18 revenues from the region declined by 17 per cent year-on-year. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 6, 2018 Category: Pharmaceuticals Source Type: news

'In the times to come, we will transform illness to wellness centers'
New Delhi, June 2018: The Economic Times Doctors Day Conclave, 2018 brought some of the finest healthcare professionals under one roof and delved into issues... (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 5, 2018 Category: Pharmaceuticals Source Type: news

Suven Life gets product patents from India, S. Korea and Singapore
Suven Life Science said it has been granted a product patent by India, Singapore, South Korea and Israel each for a new chemical entity (NCE). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 4, 2018 Category: Pharmaceuticals Source Type: news

Unichem Labs gets USFDA nod for asthma drug
The tablets are indicated for prophylaxis and chronic treatment of asthma in adults and pediatric patients - 12 months of age and older. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 4, 2018 Category: Pharmaceuticals Source Type: news

Shut Chinese companies hit desi pharma players
The shakeup in Chinese factories in the wake of environmental concerns is sending shivers down the spine of the domestic drug industry, with many fearing there will be supply disruptions and inflationary pressures. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 3, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma gets approval to manufacture pain reliever Ibuprofen
"The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture Ibuprofen capsules OTC, 200 mg," Pharma said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 2, 2018 Category: Pharmaceuticals Source Type: news

Natco Pharma launches Hepatitis C drug in India
Natco Pharma launched fixed dose combination of Sofosbuvir-Daclatasvir tablets for the treatment of Hepatitis C under the brand name Hepcinat Plus. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 2, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy's recalls 2.36 lakh bottles of cholesterol lowering tablets from US
A class III recall is initiated in a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 1, 2018 Category: Pharmaceuticals Source Type: news

Government plans to cap drug prices at first point of sale
At present, the government caps prices of essential drugs based on the average ‘price to retailer’ of all brands of any particular medicine with at least 1% market share. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 29, 2018 Category: Pharmaceuticals Source Type: news

New J & J TB drug not without side effects: Sir John Walker
The 1997 Nobel winner in chemistry, who was one of the speakers at the Lindau Nobel Laureates meeting, said clinical data showed that the drug has side effects. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 29, 2018 Category: Pharmaceuticals Source Type: news

Lupin-Mylan team up for biosimilar Etanercept
Under the terms of the agreement, Lupin will receive an up-front payment of $15 million and potential commercial milestones together with an equal share in net profits of the product. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 28, 2018 Category: Pharmaceuticals Source Type: news

Oxytocin formulations ban to come into effect from July 1
From July 1, no private manufacturer will be allowed to manufacture Oxytocin for domestic use. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 27, 2018 Category: Pharmaceuticals Source Type: news

Lupin to launch nearly 30 products in US market in FY18
The drug firm is banking on the introduction of complex generics and biosimilars in the US to maintain its top five position in the market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 24, 2018 Category: Pharmaceuticals Source Type: news

Package rates in Ayushman Bharat scheme will put patient safety at stake: IMA
In an emergency meeting, the IMA said the package rates were "unacceptable" but appreciated the government's decision to empanel the hospitals from 10 beds onwards. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 24, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy's loses patent case with Eli Lilly over Alimta
The U.S. District Court for the Southern District of Indiana ruled in favor of Lilly, a release from the US drug maker said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 24, 2018 Category: Pharmaceuticals Source Type: news

Need for collaborative teaching programmes in health care technology: Harsh Vardhan
The Union Minister also called for the institutionalisation of scientific, medical and technology communities across the country for better results. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 23, 2018 Category: Pharmaceuticals Source Type: news

Add a dose of Harvard to the Bezos-Buffett-Dimon health mix
One of Atul Gawande's targets as the head of Amazon, Berkshire Hathaway and JPMogran's new healthcare venture will be health insurer profits. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 21, 2018 Category: Pharmaceuticals Source Type: news

USFDA approves first product from Glenmark's US plant
The US Food and Drug Administration has provided its first supplemental Abbreviated New Drug Application approval for the company's plant in Monroe, Glenmark (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 19, 2018 Category: Pharmaceuticals Source Type: news

Piramal Capital sanctions Rs 200 crore funding to Chennai ’s Appaswamy Group
The structured equity funding will enable the acquisition of 3.34 acre land in Chennai ’s Kotturpuram locality, the Piramal Group company said in a release. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 18, 2018 Category: Pharmaceuticals Source Type: news

Lupin, Nichi-Iko tie up for commercialization of biosimilar Etanercept in Japan
Mumbai based Lupin pharma and Japan's Nichi-Iko have tied up for the distribution, promotion and sale of Lupin ’s recently-filed biosimilar Etanercept in Japan. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 18, 2018 Category: Pharmaceuticals Source Type: news

Big pharmaceutical companies face action for marketing unapproved drugs
The Centre is trying to plug a legal loophole that allows major drug manufacturers to sell and market products, such as emergency contraceptives and anti-obesity and fertility formulations, which haven ’t undergone clinical trials to establish their risk and efficacy. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 17, 2018 Category: Pharmaceuticals Source Type: news

Lupin expects single digit sales growth this fiscal
The drug maker reported negative growth in 2017-18 for the first time in a decade, with net sales dropping to Rs 15,560 crore, a decline of 9 per cent from 2016-17. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 17, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy's gets temporary restraining order on sale of generic Suboxone film in US
Dr Reddy's said in a BSE filing that the company remains confident in its legal positions on this patent. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 16, 2018 Category: Pharmaceuticals Source Type: news

Temporary restraining order for Dr Reddy ’s in US
It is indicated for treatment of opioid dependence. Dr Reddy ’s said in a BSE filing that the company remains confident in its legal positions on this patent. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 16, 2018 Category: Pharmaceuticals Source Type: news

Our aim is to be among top 10 players in India: Rajiv Malik of Mylan
The Nasdaq-listed company will work with the government to expand affordable healthcare for infectious diseases such as HIV and tuberculosis, president Rajiv Malik said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 15, 2018 Category: Pharmaceuticals Source Type: news

Alembic Pharma receives EIR from USFDA
USFDA releases a copy of the EIR to the establishment that was the subject of an FDA or FDA-contracted inspection when the agency determines the inspection to be closed. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 15, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy's Laboratories gets USFDA nod for generic version of Suboxone
The company, which is launching the product in the US, said approval has been granted in the strengths of 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 15, 2018 Category: Pharmaceuticals Source Type: news

Lupin gets USFDA approval for generic contraceptive drug
The company has received final approval from the USFDA to market its product which is a generic version of Bayer HealthCare Pharmaceutical Inc's Beyaz tablets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 14, 2018 Category: Pharmaceuticals Source Type: news

Alembic Pharma gets USFDA nod for its antibiotic capsules
The approval from USFDA is for the company's abbreviated new drug application (ANDA) in the strengths of 50 mg and 100 mg, Alembic Pharma said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 14, 2018 Category: Pharmaceuticals Source Type: news

Lupin launches generic antibiotic inhalation solution in US
The company has launched the product as it has received an approval from the US Food and Drug Administration (USFDA) earlier, Lupin said in a filing to BSE. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 13, 2018 Category: Pharmaceuticals Source Type: news

NPPA fixes prices of 22 drug formulations
While National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 20 formulations, it has also capped the ceiling prices of two formulations, a notification on the regulator's website said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 13, 2018 Category: Pharmaceuticals Source Type: news

China to conduct training programmers for Indian pharmaceutical companies
The move assumes significance as it takes years for Indian pharmaceutical companies to obtain regulatory clearances for their products in China. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 12, 2018 Category: Pharmaceuticals Source Type: news

USFDA clears Sun Pharma ’s Halol plant, two years after it went under import ban
The USFDA ’s Establishment Inspection Report (EIR) comes days after the company received Voluntary Action Indicated (VAI) that indicated that clearance for the plant wasn’t too far away. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 12, 2018 Category: Pharmaceuticals Source Type: news